Trial Profile
A Randomized, Open-label, Single-dosing, Crossover Study to Compare the Safety and Pharmacokinetics of CKD-330(Fixed-dose Combination of Candesartan Cilexetil 8 mg and Amlodipine 5 mg) With Coadministration of the Two Separate Drugs in Healthy Male Volunteers(B)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Amlodipine/candesartan-cilexetil (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 04 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Sep 2015 New trial record